The EU has agreed to provide ‘solidarity vaccines’ to five member states and the WHO has published a progress report on its assessments of COVID-19 vaccines.
Moderna, Inc.’s RNA-1273 has become the first COVID-19 vaccine to receive a conditional marketing authorization (CMA) in Great Britain under a new mechanism introduced at the beginning of the year.
It has also just been launched in Wales, with the first doses to be administered from the West Wales General...
<p>Executive Summary</p> <p>A list of EU biosimilar filings, CHMP opinions and EU marketing authorizations, including details of the biosimilar company, the brand name/INN, indication(s), the reference product/company, and the date and type of event.</p>
As the reform of the EU pharmaceutical legislation progresses through the legislative process, the Pinks Sheet offers an infographic highlighting some of the key changes being proposed that will reshape the way drug companies run their business.
<p>Executive Summary<p> <p>The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add six new products, incl/ding Ixchiq, Valneva's chikungunya virus vaccine</p>
The Pink Sheet highlights recent comments and insights from pharma officials and executives on key issues we are covering.
A new research ethics review system for multi-site clinical trials in Canada is expected to help improve study start-up times, avoid unnecessary duplication and boost the country’s competitiveness on a global stage.
